Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale

International Journal of Stroke

Volumn 7, Issue 8, 2012, Pages 631-634

  Arauz, Antonio ^a   Murillo, Luis ^b   Márquez, Juan Manuel ^a   Tamayo, Arturo ^c,g   Cantú, Carlos ^d   Roldan, Francisco Javier ^e   Vargas Barrón, Jesús ^e   Barinagarrementeria, Fernando ^f  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^c Brandon Regional Health Centre   (Canada)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^f UNIVERSIDAD DEL VALLE DE MÉXICO   (Mexico)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cryptogenic ischemic stroke; Patent foramen ovale; Stroke recurrence

Indexed keywords

ACETYLSALICYLIC ACID;

ADOLESCENT; ADULT; ANEURYSM; ARTICLE; ATRIAL SEPTAL ANEURYSM; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SECONDARY PREVENTION; TRANSIENT ISCHEMIC ATTACK;

ADOLESCENT; ADULT; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; FORAMEN OVALE, PATENT; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84869016110     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00641.x     Document Type: Article

References (19)

1. Sacco RL, Ellenberg JH, Mohr JPet al. Infarcts of undetermined cause: the NINDS stroke data bank. Ann Neurol 1989; 25:382-90.
2. Mas JL, Zuber M.Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French study group on patent foramen ovale and atrial septal aneurysm. Am Heart J 1995; 130:1083-8.
3. Mas JL, Arquizan CCoste J for the PFO andASA study group.et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345:1740-6.
4. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G.Stroke recurrence in patients with patent foramen ovale: the Lausanne study: Lausanne stroke with paradoxical embolism study group. Neurology 1996; 46:1301-5.
5. Nedeltchev K, Arnold M, Wahl A.Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychitry 2002; 72:347-50.
6. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DK, Hill MD.Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 2009; 73:89-97.
7. Adams HP, Bendixen BH, Kappelle LJ.Classification of subtype of acute ischemic stroke: definition for use in a multicenter clinical trial. TOAST: trial of Org 10172 in acute stroke treatment. Stroke 1993; 24:35-41.
8. Attaran R, Ata I, Kudithipudi V, Foster L, Sorrel V.Protocol for optimal detection and exclusion of a patent foramen ovale using transthoracic echocardiography with agitated saline microbubbles. Echocardiography 2006; 23:616-22.
9. Zito C, Dattilo G, Oreto Get al. Patent Foramen Ovale: comparison among diagnostic strategies in cryptogenic stroke and migraine. Echocardiography 2009; 26:495-503.
10. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow Ch.Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire community stroke project. Stroke 1994; 25:333-7.
11. Homma S, Sacco RL, Di Tulio MR, Sciacca RR, Mohr JPPFO in cryptogenic stroke study (PICCS) investigatorsEffect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 2002; 105:2625-31.
12. Serena J, Mart-Fabregas J, Santamarina Eet al. Recurrent stroke and massive right to left shunt. Results from the prospective Spanish multicenter (CODICIA) study. Stroke 2008; 39:3131-6.
13. Weimar C, Holle DNon behalf of the German Stroke Study Collaboration.et al. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis 2009; 28:349-56.
14. De Castro S, Cartoni D, Fiorelli M.Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000; 31:2407-13.
15. Homma S, Sacco R.Patent foramen ovale and stroke. Circulation 2005; 112:1063-72.
16. Tamayo A, Harrer JU.Patent foramen ovale and ischemic stroke recurrence. The end of a never-ending story?Neurology 2009; 73:84-5.
17. Lamy C, Giannesini C, Zuber Met al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Stroke 2002; 33:706-11.
18. Gautier JC, Dürr A, Koussa S, Lascault G, Grosgogeat Y.Paradoxical cerebral embolism with a patent foramen ovale. A report of 29 patients. Cerebrovasc Dis 1991; 1:193-202.
19. Ozdemir O, Tamayo A, Muñoz C, Dias B, Spence JD.Cryptogenic stroke and patent foramen ovale; clinical clues to paradoxycal embolism. J Neurol Sci 2008; 275:121-7.